JP2024546944A5 - - Google Patents
Info
- Publication number
- JP2024546944A5 JP2024546944A5 JP2024535917A JP2024535917A JP2024546944A5 JP 2024546944 A5 JP2024546944 A5 JP 2024546944A5 JP 2024535917 A JP2024535917 A JP 2024535917A JP 2024535917 A JP2024535917 A JP 2024535917A JP 2024546944 A5 JP2024546944 A5 JP 2024546944A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- heterocyclyl
- halogen
- alkynyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163289822P | 2021-12-15 | 2021-12-15 | |
| US63/289,822 | 2021-12-15 | ||
| PCT/US2022/081514 WO2023114818A1 (en) | 2021-12-15 | 2022-12-14 | Naphthalene and quinoline analogs as rxfp1 agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546944A JP2024546944A (ja) | 2024-12-26 |
| JP2024546944A5 true JP2024546944A5 (https=) | 2025-12-16 |
Family
ID=85227073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535917A Pending JP2024546944A (ja) | 2021-12-15 | 2022-12-14 | Ｒｘｆｐ１アゴニストとしてのナフタレンおよびキノリン類似体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250100960A1 (https=) |
| EP (1) | EP4448504A1 (https=) |
| JP (1) | JP2024546944A (https=) |
| KR (1) | KR20240122836A (https=) |
| CN (1) | CN118414330A (https=) |
| WO (1) | WO2023114818A1 (https=) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9452973B2 (en) * | 2012-05-04 | 2016-09-27 | The United States Of America, As Represented By The Secretary Department Of Health And Human Services | Modulators of the relaxin receptor 1 |
-
2022
- 2022-12-14 WO PCT/US2022/081514 patent/WO2023114818A1/en not_active Ceased
- 2022-12-14 JP JP2024535917A patent/JP2024546944A/ja active Pending
- 2022-12-14 US US18/718,470 patent/US20250100960A1/en active Pending
- 2022-12-14 KR KR1020247023156A patent/KR20240122836A/ko active Pending
- 2022-12-14 CN CN202280083083.8A patent/CN118414330A/zh active Pending
- 2022-12-14 EP EP22857055.2A patent/EP4448504A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540164A5 (https=) | ||
| JP2024540163A5 (https=) | ||
| JP5337479B2 (ja) | 新規化合物 | |
| JP2024546943A5 (https=) | ||
| JP2018508569A5 (https=) | ||
| JP2012522759A5 (https=) | ||
| JP2010526145A5 (https=) | ||
| JP2020526484A5 (https=) | ||
| RU2006112428A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| JP2009108048A (ja) | 分子シャペロン産生を増強するのに有用なヒドロキシルアミン誘導体およびそれの調製 | |
| JP2006265257A (ja) | Ｖｃａｍ−１発現を阻害する化合物および方法 | |
| JP2014513046A (ja) | ４−ヒドロキシ酪酸の重水素化類似体 | |
| JP2023535453A5 (https=) | ||
| JP2024546944A5 (https=) | ||
| AU2006236534A1 (en) | Methods of increasing natural killer cell activity for therapy | |
| JP2022530051A5 (https=) | ||
| US20060106082A1 (en) | Nitrooxyderivatives of cyclooxygenase-2 inhibitors | |
| US5686621A (en) | Substituted hydrindanes for the treatment of angiogenesis-dependent diseases | |
| JP6454335B2 (ja) | カテプシンシステインプロテアーゼ阻害剤 | |
| JP2024546946A5 (https=) | ||
| JP3110515B2 (ja) | スルホンアミド誘導体 | |
| JP2022537350A5 (https=) | ||
| JP2024540161A5 (https=) | ||
| JP2021520394A5 (https=) | ||
| JP2025503442A5 (https=) |